As part of a global response to the many challenges faced by women with advanced breast cancer, applicants may consider the following guiding questions: How can we respond to these challenges in new and innovative ways? How will we know if we have made change? What are the mechanisms we can employ to sustain that change over time? Will our projects and programmes carry lessons for other organizations? What is our organization’s value-added local and global response?
Given that all successful applications will fund novel projects that the organization has not yet done before, there are several layers of support to help guide the implementation, evaluation, and sustainability processes. Volunteer mentors may be assigned to an organization, a best practice network will be available for collaboration and resource-sharing, and workshops will be held for grantees.
In addition to offering real-time guidance to grantee organizations, these support structures will also fulfil the mission of the Pfizer-UICC partnership to ensure that the gains made and the lessons learned are documented, understood, and shared widely. Each mechanism is described in further detail below.
Organizations may be paired with a volunteer mentor who will provide guidance to the team implementing the awarded project. The UICC will suggest mentors that are experts in their field and have recent experience in the topic the grantee is addressing.
(2) Best Practice Network
Grantees (and applicants) are encouraged to join the UICC Breast Cancer Advocates Best Practice Network, which is part of the International Cancer Control Partnership. SPARC affiliates are encouraged to participate, download resources, seek advice, and network with UICC members. Selected strong members may be invited to twin with Grantees in line with a long-term vision for collaboration beyond the 18-month grant period. These twins provide support to grantees starting mid-way through the grant timeline, and specifically advise grantees on sustaining their project in the mid to long term.